期刊文献+

TRAIL、MMP-2及TIMP-2在大肠癌中的表达及意义的研究 被引量:8

Expression and significance of TRAIL,MMP-2 and TIMP-2 in colorectal carcinoma
下载PDF
导出
摘要 目的研究肿瘤坏死因子相关凋亡诱导配体(TRAIL)、MMP-2、TIMP-2在大肠癌中的表达及意义,探讨TRAIL诱导肿瘤细胞凋亡的可能机制,MMP-2及TIMP-2在肿瘤的侵袭和转移中的重要的作用及相互关系,寻求提高TRAIL对肿瘤细胞敏感性的可能途径。方法采用SP法检测102例大肠癌及其癌旁5cm组织、25例正常大肠黏膜组织中TRAIL、MMP-2及TIMP-2蛋白的表达水平。结果 TRAIL在大肠癌、癌旁组织及正常大肠黏膜组织中的表达呈明显递增趋势(P<0.01);MMP-2在大肠癌、癌旁组织及正常大肠黏膜组织中的表达呈明显递减趋势(P<0.01);TIMP-2在大肠癌、癌旁组织及正常大肠黏膜组织中的表达无统计学意义(P>0.05)。TRAIL在中、低分化癌中的表达明显低于高分化癌中的表达(P=0.003)。结论 TRAIL、MMP-2及TIMP-2可能与大肠癌的发生、发展、侵袭及转移密切相关;MMP-2与TIMP-2在癌组织中表达失衡在肿瘤的侵袭及转移中可能起重要作用。通过改善MMP-2与MMP-2在癌组织中表达的失衡,可能提高TRAIL对肿瘤细胞的特异性杀伤效率及改善肿瘤患者的预后。 Objective To investigate the expression and significance of TRAIL,MMP-2,TIMP-2 in colorectal carcinoma,and to observe the effect of MMP-2 and TIMP-2 on the anti-tumor activity of TRAIL,and to explore the apoptosis mechanism induced by TRAIL and to seek the way to increase the sensitivity of anti-tumor effect by TRAIL.Methods The immunohistochemical technique (SP) was used to detect the expression of TRAIL,MMP-2 and TIMP-2 in 102 cases of colorectal carcinoma and the surrounding tissues of 5cm distance and 25 cases of normal colorectal mucosa.Results The expression of TRAIL in colorectal carcinoma,surrounding tissues and normal colorectal mucosa was different and the tendency of increase in turn was quite obvious(P0.01).The expression of MMP-2 in colorectal carcinoma,surrounding tissues and normal colorectal mucosa was different,and the decrease tendency in turn was very obvious(P0.01).The expression of TIMP-2 in colorectal carcinoma,surrounding tissues and normal colorectal mucosa had no significant differences(P0.05).Conclusion The TRAIL,MMP-2 as well as TIMP-2 may be closely related with the pathogenesis,development,invasion and metastasis of colorectal carcinoma.The unbalance of MMP-2 expression may play an important role in the invasion and metastasis of colorectal carcinoma.To improve the unbalance of MMP-2 and MMP-2 expression in tumor tissue can enhance the specific killing efficiency of TRAIL on tumor cells and can improve the prognosis of patients with colorectal carcinoma.
出处 《河北医药》 CAS 2011年第7期972-974,共3页 Hebei Medical Journal
基金 石家庄市科学技术研究与发展指导计划项目(编号:09146473)
关键词 肿瘤坏死因子相关凋亡诱导配体 MMP-2 TIMP-2 结直肠肿瘤 免疫组织化学 TRAIL MMP-2 TIMP-2 colorectal neoplasm immunohistochemistry
  • 相关文献

参考文献5

  • 1Kim Y, Seol DW. TRAIL, a mighty apoptosis inducer. Mol Cells,2003, 15:283-293.
  • 2Ellerbroek SM, Hudson LG,Stack MS. Proteinase requirements of epider- mal growth factor-induced ovarian cell invasion. Im J Cancer, 1998,78: 331-337.
  • 3Ohuchi E, Imai K, Fuji, Y, etal. Membrane Type 1 Matrix Metalloprotein- ase Digests Interstitial Collagens and Other Extracellular Matrix Macro- molecules J Biol Chem, J 997,272:2446-2451.
  • 4DOrtho MP, Will H ,Atkins0n S,et al. Membrane-type matrix metallopro- teinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biocbem, 1997,250:751-757.
  • 5Murphy AN, Unsworth E J, Steler Stevenson WG0 et al. Tissue inhibitor of metalloproteinases 2 inhibits bFGF induced human microvascnler endo- thelial cellproliferation ,J Cell Physiol, 1993,157:351-357.

同被引文献62

  • 1郝凤进,张勇.CD147与MMP-9蛋白在大肠癌中的表达[J].中国医科大学学报,2009,38(5):321-323. 被引量:4
  • 2刘耀明,周敏慧,徐崇宏,张彦博,石鹏飞,李晓鸣.RANKL、OPG、TRAIL在骨肉瘤中的表达及其临床意义[J].临床军医杂志,2010,38(4):509-511. 被引量:1
  • 3周文鹏,吴金民,张行,潘宏铭,方勇,曹厚军,王宏,张俊平,张在云.大肠癌患者血清IL-8和MMP-3水平的临床研究[J].实用肿瘤杂志,2006,21(3):237-239. 被引量:4
  • 4Gniffith TS, Lynch DH. Trail: a molecule with multiple receptor and control mechanisms[J]. Curr Opin Immunol, 1998,10 (5) :559-63.
  • 5Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of a new member of the TNF family that in duces apoptosis[J]. Immunity, 1995,3(6) :673-82.
  • 6Spienings DC, de Vries EG, Vellenga E, et al. Tissue distribution of the death ligaand TRAIL and its receptors[J]. J Histochem Cytochem, 2004,52 (6): 821-31.
  • 7Chen Q, Ray S, Hussein MA, et al. Role of Apo2L/TRAIL and Bcl-2-family proteins in apoptosis of multiple myeloma [J]. Leuk Lymphoma, 2003,44 (7) : 1209-14.
  • 8Kim Y, Seol DW. TRAIL, a mighty apoptosis inducer [J]. Mol Cells, 2003,15 ( 3 ) : 283-93.
  • 9Buchsbaum DJ, Zhou T, Lobuglio AF, et al. TRAIL receotortargeted therapy[J]. Future Oncol ,2006,2(4):493-508.
  • 10Kischkel FC, Lawrence DA, Chuntharapai A, et al. Apo2L/ TRAIL dependent revruitment of endogenous FADD and easpase-8 to srath receptors 4 and 5 [J]. Irnmunity, 2000,12 (6):611-20.

引证文献8

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部